>
His grandparents had heart disease.
At 11, Laurent Simons decided he wanted to fight aging.
Something is off about this cruise ship in the Atlantic with the Hantavirus outbreak
Are Chemtrails Real or Just a Conspiracy Theory? | Make This Make Sense
A multi-terrain robot from China is going viral, not because of raw speed or power...
The World's Biggest Fusion Reactor Just Hit A Milestone
Wow. Researchers just built an AI that can control your body...
Google Chrome silently installs a 4 GB AI model on your device without consent
The $5 Battery That Never Dies - Edison Buried This 100 Years Ago
That is not a real fish. IT'S A ROBOT.
Scientists Unveil Hemp Alternative to Plastic That Can Withstand Boiling Water...
A Robot Economy: Who Gets Rich, Who Gets Left Behind
Is Surveillance Pricing Ripping You Off? How to Stop Your Data from Being Used Against You
Robot Dives 1.5 Miles, Maps French Shipwreck With 86,000 Images And Recovers Artifacts

A groundbreaking study published in the Journal of Biomolecular Structure and Dynamics suggests just that — revealing how a natural compound found in licorice root might be a powerful weapon against breast cancer.
The sweet science behind glycyrrhizin
Glycyrrhizin, the active ingredient in licorice root responsible for its sweetness, has been used for centuries in traditional medicine to treat everything from sore throats to digestive issues. But now, researchers are uncovering its potential as a natural cancer-fighting agent. (Related: Licorice contains powerful cancer-killing phytochemicals.)
Using advanced computer modeling and bioinformatics — a subdiscipline of biology and computer science that uses software tools to analyze and interpret biological data — Iranian researchers mapped out exactly how this compound interacts with breast cancer cells, and the results are promising.
The study dug deep into the molecular pathways glycyrrhizin takes to combat cancer. Specifically, it focused on the breast cancer genes glycyrrhizin targets and how the compound interacts with the genes' protein products.
Of the 10 breast cancer-related genes the researchers looked at, they found that glycyrrhizin showed the highest binding affinity to three genes, namely, POLK, TBXAS1 and ADRA1A. These genes are active in three types of breast cancer: breast carcinoma, malignant neoplasm of the breast and triple-negative breast neoplasms.
The researchers reported that the protein products of these genes "had an association with [breast cancer] at several stages of tumor growth." By binding to and influencing the activities of these targets, glycyrrhizin is able to influence and control breast cancer growth and survival efficiently.
Molecular dynamics simulation also revealed that of the three interactions mapped out by the study, the destructive pathways triggered by glycyrrhizin's binding to ADRA1A had the highest likelihood of occurring.